Abstract
Chronic obstructive pulmonary disease is one of the most common disease affecting millions of people worldwide. It is a multicomponent disease which beside airflow obstruction causes airway inflammation, structural changes, mucociliary dysfunction and systemic dysfunction. Airway responsiveness is altered during sleep along with decrease in ventilation due to reduction in tidal volume. Patients with COPD also develop significant nocturnal desaturation despite adequate oxygenation during the wake state. Almost 14% of patients with COPD also have concurrent obstructive sleep apnea, which in turn can lead to more desaturation, hypoxia and hypercarbia. The COPD can affect the quality of life by causing insomnia, excessive day time sleepiness, fatigue, morning awakening, and poor sleep quality. In the current article we will address the issues of oxygenation during sleep, effects of combination of COPD and OSA, quality of sleep in COPD patients and different therapeutic options to counter the effects of COPD on sleep.
Keywords: Obstructive sleep apnea, sleep and COPD, sleep in medical disorder
Current Respiratory Medicine Reviews
Title: Sleep and COPD
Volume: 5 Issue: 4
Author(s): Salim Surani
Affiliation:
Keywords: Obstructive sleep apnea, sleep and COPD, sleep in medical disorder
Abstract: Chronic obstructive pulmonary disease is one of the most common disease affecting millions of people worldwide. It is a multicomponent disease which beside airflow obstruction causes airway inflammation, structural changes, mucociliary dysfunction and systemic dysfunction. Airway responsiveness is altered during sleep along with decrease in ventilation due to reduction in tidal volume. Patients with COPD also develop significant nocturnal desaturation despite adequate oxygenation during the wake state. Almost 14% of patients with COPD also have concurrent obstructive sleep apnea, which in turn can lead to more desaturation, hypoxia and hypercarbia. The COPD can affect the quality of life by causing insomnia, excessive day time sleepiness, fatigue, morning awakening, and poor sleep quality. In the current article we will address the issues of oxygenation during sleep, effects of combination of COPD and OSA, quality of sleep in COPD patients and different therapeutic options to counter the effects of COPD on sleep.
Export Options
About this article
Cite this article as:
Surani Salim, Sleep and COPD, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112465
DOI https://dx.doi.org/10.2174/157339809790112465 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nephroangiosclerosis and Its Pharmacological Approach
Current Vascular Pharmacology Is Later Obesity Programmed In Utero?
Current Drug Targets Evolution of Global and Local Grey Matter Atrophy on Serial MRI Scans During the Progression from MCI to AD
Current Alzheimer Research A Simple and Precise Determination of Diltiazem Hydrochloride by Simultaneous Conductometric and Potentiometric Detection
Current Pharmaceutical Analysis Pharmacological Manipulation of Peripheral Vascular Resistance in Single Ventricle Patients (Stages I, II, and III of Palliation)
Current Vascular Pharmacology The Vascular Endothelin System in Hypertension - Recent Patents and Discoveries
Recent Patents on Cardiovascular Drug Discovery Influence of Vanin-1 and Catalytic Products in Liver During Normal and Oxidative Stress Conditions
Current Medicinal Chemistry Serum Uric Acid is Independently Associated with Diastolic Dysfunction in Apparently Healthy Subjects with Essential Hypertension
Current Vascular Pharmacology Medical Treatment of Chronic Venous Insufficiency
Vascular Disease Prevention (Discontinued) Diuretics in the Treatment of Elderly Hypertensive Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry From Cerebrospinal Fluid Pulsation to Noninvasive Intracranial Compliance and Pressure Measured by MRI Flow Studies
Current Medical Imaging Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth
Current Drug Targets Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs
Current Molecular Pharmacology Mitochondrially Targeted Antioxidants for the Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease
Current Pharmaceutical Design An Umbrella Review of Nuts Intake and Risk of Cardiovascular Disease
Current Pharmaceutical Design Coronary Stent Fracture: A Recently Appreciated Phenomenon with Clinical Relevance
Current Cardiology Reviews Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Kinins and Cardiovascular Diseases
Current Pharmaceutical Design Validated Spectrodensitometric Method for Simultaneous Estimation of Sofosbuvir, Ribavirin and Saxagliptin in their Pure and Pharmaceutical Dosage Forms
Current Pharmaceutical Analysis